Polypoidal Choroidal Vasculopathy (PCV): Clinical Trials

4 trials for Polypoidal Choroidal Vasculopathy (PCV), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting, 1 unknown. 2 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 32Recruiting 2
Phase 42Not yet recruiting 1, Unknown 1

Follow Polypoidal Choroidal Vasculopathy (PCV): new trials by email Literature Review of Polypoidal Choroidal Vasculopathy (PCV) trials Research Report on Polypoidal Choroidal Vasculopathy (PCV)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial
aflibercept 8 mg - Polypoidal Choroidal Vasculopathy, Polypoidal Choroidal Vasculopathy (PCV)
Phase 3RecruitingYeungnam University College of Medicine502026-12-242026-02-05
Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy
Faricimab Injection [Vabysmo] - Polypoidal Choroidal Vasculopathy (PCV), Age Related Macular Degeneration
Phase 3RecruitingYeungnam University College of Medicine502026-03-012026-03-10
A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)
Aflibercept Intravitreous Injection - Polypoidal Choroidal Vasculopathy (PCV), Neovascular Age Related Macular Degeneration (AMD)
Phase 4Not yet recruitingShanghai General Hospital, Shanghai Jiao Tong University School of Medicine1742026-01-012026-01-26
The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)
Conbercept - Polypoidal Choroidal Vasculopathy (PCV)
Phase 4UnknownChengdu Kanghong Biotech Co., Ltd.3002015-10-012017-07-19

Narrower conditions

Polypoidal Choroidal Vasculopathy (4)  ·  Macular Degeneration (1)

Broader conditions

Choroid Diseases (4)  ·  Choroidal Neovascularization (4)  ·  Eye Diseases (4)  ·  Metaplasia (4)  ·  Neovascularization, Pathologic (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Uveal Diseases (4)  ·  Retinal Degeneration (1)  ·  Retinal Diseases (1)

Interventions

KH902 fusion protein (1)  ·  aflibercept (1)  ·  faricimab (1)

Sponsors

Yeungnam University College of Medicine (2)  ·  Chengdu Kanghong Biotech Co., Ltd. (1)  ·  Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

China (2)  ·  South Korea (2)